Publications
249
Citations
21,503
Est. group size
~17
Recurring co-author estimate
Active years
36
Publishing since 1991
Typically publishes in teams of ~12 · 36% small-team papers (≤3 authors) · across 21 venues
- NAB2::STAT6 fusion proteins drive nuclear condensate formation and transcriptional reprogramming in solitary fibrous tumors
Cancer Letters · 2026
- Abstract 4737: Utilizing patient-derived organoid tumor models to combat chemo-immunotherapy resistance in NSCLC
Cancer Research · 2026
- Abstract 1338: DPP-4: A CD8+ T cell metabolic checkpoint and cancer immunotherapy target.
Cancer Research · 2026
- Pharmacologic DPP-4 inhibition promotes CD8⁺ T cell metabolic fitness to enhance anti-tumor activity
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients
EMBO Molecular Medicine · 2026
- Supplementary Figure 11 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 5 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 3 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 1 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 9 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 12 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 2 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 13 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 10 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Supplementary Figure 8 from GPR1 and CMKLR1 Control Lipid Metabolism to Support the Development of Clear Cell Renal Cell Carcinoma
2026
- Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature×30
- bioRxiv (Cold Spring Harbor Laboratory)×13
- Cancer Research×7
- Neuro-Oncology×3
- Elsevier eBooks×3
- William Giblin
Medicine · University of Michigan
- Mary E. Skinner
Medicine · University of Michigan
- Yanghan Liu
Medicine · University of Michigan
- Surinder Kumar
Medicine · University of Michigan
- Eswar Shankar
Biochemistry, Genetics and Molecular Biology · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile